KOD - Kodiak Sciences Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.075M

Cash

245.9M

Avg Qtr Burn

-36.64M

Short % of Float

6.02%

Insider Ownership

5.67%

Institutional Own.

82.88%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tarcocimab (KSI-301) (anti-VEGF) Details Non-proliferative diabetic retinopathy	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-501 (anti-VEGF & IL-6) Details Eye disease , Wet age-related macular degeneration	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-101 Details Eye disease	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-501 (anti-VEGF & IL-6) Details Diabetic macular edema, Eye disease	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tarcocimab (KSI-301) Details Wet age-related macular degeneration	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tarcocimab (KSI-301) (anti-VEGF) Details Diabetic macular edema	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tarcocimab (KSI-301) Details Retinal vein occlusion	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.